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The Rheumatoid Hand: A Predictable Disease
With Unpredictable Surgical Practice Patterns
AMY K. ALDERMAN,1 KEVIN C. CHUNG,2 SONYA DEMONNER,3 SANDRA V. SPILSON,4
AND RODNEY A. HAYWARD5
Objectives. To evaluate variation in fusion, arthroplasty, and tenosynovectomy rates among rheumatoid arthritis (RA)
patients across states; to evaluate associations between surgery rates and the density of hand surgeons; and to evaluate
differences in treatment by sex of the patient.
Methods. Data were obtained from the 1996 and 1997 Healthcare Cost and Utilization Project database. The procedure
codes for fusion, arthroplasty, and tenosynovectomy were matched to patients with the diagnostic code of RA, which
provided the total number of procedures performed in each state. The smoothed estimates of the RA population for each
state were derived from age/sex strata in the 1995 US census using age/sex-adjusted RA prevalence data from the Third
National Health and Nutrition Examination Survey. The number of hand surgeons was from the 1996 American Society
for Surgery of the Hand.
Results. Procedure rates across states varied from 9-fold to 12-fold for all 3 procedures. The rates of the reconstructive
procedures—fusion and arthroplasty—were highly correlated in each state, but these 2 procedures were only moderately
correlated with tenosynovectomy. Surgeon density and procedure rates were minimally correlated. Procedure rates differed
by patient sex, with significantly more arthroplasty and fusion procedures performed in women. More tenosynovectomy
procedures were performed in men, and they were also performed at a younger age in men.
Conclusions. Significant large area variations are present in the surgical management of the rheumatoid hand, but the
correlations between reconstructive and early intervention procedures are modest. These rate differences are not
explained by the number of hand surgeons, disease prevalence, or demographic composition of the states. However, men
are more likely to receive more aggressive early surgical interventions, and women are more likely to receive end-stage
reconstructive surgery.
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INTRODUCTION
Rheumatoid arthritis (RA) is a debilitating and progressive
disease, affecting an estimated 2.1 million Americans (1).
Although RA is a systemic disease extending beyond the
musculoskeletal system, more than 70% of RA patients
have some form of hand disability (2). The disease often
progresses to crippling hand deformities despite aggres-
sive medical treatment, and few patients ever achieve dis-
ease control (3).
The role of surgery in the rheumatoid hand has been
controversial, with rheumatologists and surgeons debating
the efficacy of surgical treatments. This controversy may
result in uncertainty in patient management, which can
lead to large variation in surgical practice across the coun-
try (4). Furthermore, given the uncertainty of treatment
efficacy cited in the medical literature, the rheumatoid
population may be particularly vulnerable to treatment
biases, with influences ranging from patient sex to the
density of health care providers (5–11).
The purpose of our research was to use a large, popula-
tion-based sample to evaluate surgical practice patterns of
the rheumatoid hand in the US. Specifically, we evaluated
3 surgical procedure rates across the country, looking for
evidence of geographic variation in practice patterns. We
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also evaluated aggressiveness of care between men and
women, comparing the rates of end-stage reconstructive
procedures, arthroplasty and arthrodesis, with the rates of
prophylactic tenosynovectomy. In addition, the procedure
rates were compared with the density of surgeons, assess-
ing the possibility of physician-induced demand.
MATERIALS AND METHODS
Database characteristics. We obtained data from the
1996 and 1997 Healthcare Cost and Utilization Project
(HCUP)-3 Nationwide Inpatient Sample Release 5 and 6.
This national database is sponsored by the Agency for
Healthcare Research and Quality, formerly the Agency for
Health Care Policy and Research. The project involves a
partnership between federal and state government and
industry to collect national health care data for use in
research and policy planning. For each year, the database
contains a 20% stratified sample of more than 6.5 million
hospital discharges from more than 906 hospitals, includ-
ing both academic and private institutions. The Veterans
Healthcare Administration system and ambulatory surgery
cases are excluded from the database. The database uses a
stratified probability sample of hospitals, with sampling
probabilities proportional to the number of hospitals in
each stratum. HCUP is one of a limited number of re-
sources that contains information on hospital discharges
for all payers, including Medicare, Medicaid, private in-
surance, and the uninsured.
Using the HCUP database allowed us to evaluate the
incidence of arthroplasty, arthrodesis, and tenosynovec-
tomy procedures in RA patients and to examine associa-
tions with the following variables: patient demographics,
payment information, and characteristics of the hospitals,
such as teaching status and geographic location. In addition,
the database has internal weighting factors that generate state
and national incidence estimates for the procedures.
Study population. Our target population, patients with
RA, was identified using the International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-
CM) diagnostic code 714.0. Patients were then selected
who had undergone one or more ICD-9 procedures speci-
fied for the hand: arthrodesis (81.25–81.28), arthroplasty
(81.71–81.75), and tenosynovectomy (82.33–83.42). The
arthrodesis codes include carporadial, metacarpocarpal,
metacarpophalangeal, and interphalangeal fusions. The ar-
throplasty codes include reconstruction with and without
implants of the metacarpophalangeal, interphalangeal,
carpocarpal, and carpometacarpal joints. The tenosyno-
vectomy code was a general code for all tenosynovectomy
procedures of the hand.
In 1996, 19 states were sampled, and in 1997, 22 states
were sampled. For evaluation of procedure rates across
states, we limited the study population to the 19 states
sampled from both years. This included the following
states: Arizona, California, Colorado, Connecticut, Florida,
Illinois, Iowa, Kansas, Massachusetts, Maryland, Missouri,
New Jersey, New York, Oregon, Pennsylvania, South Caro-
lina, Tennessee, Washington, Wisconsin. To compare pro-
cedure rates across states, we estimated the number of
people with RA in each state. We used the 1995 US census
to obtain the total number of men and women in each of
the sampled states for 3 different age categories (17–24
years, 25–64 years, and 65 years), and the prevalence of
RA within each age/sex stratum was obtained from the
Third National Health and Nutrition Examination Survey
(NHANES-III), which is a national database of patients’
self-assessments of health. For each state, we multiplied
the population in each of the 6 age/sex categories by the
smoothed age/sex-specific prevalence of RA to obtain our
age/sex-adjusted estimates of the RA population. The
smoothed estimates of RA prevalence use fitted estimates
derived from a regression model to increase the precision
of the estimates and decrease the effects of outliers and
random variation. For example, Arizona had 137,424
women between the ages of 17 and 24. This figure was
multiplied by 0.003 (the prevalence of RA in women in
this age group) to give an estimated 412 women with RA
aged 17–24. The adjusted estimates controlled for the in-
creased prevalence of RA in women and older age groups.
We limited all analyses to whites, because nonwhites have
low RA prevalence rates and account for a minority of the
NHANES-III sample. Therefore, the age/sex-adjusted RA
prevalence rates could not be accurately estimated.
The number of hand surgeons in each state was obtained
from the 1996–1997 American Society for Surgery of the
Hand (ASSH) active membership registry, which includes
both orthopedic and plastic hand surgeons and excludes
retired members. We felt that this organization would give
us the best representation of surgeons who trained in and
are practicing hand surgery and who have a special exper-
tise in complicated hand reconstruction for the rheuma-
toid population. The density of surgeons per state was
derived by dividing the total number of surgeons in a state
by that state’s total population.
Ideally, those members of the RA population who have
already had surgery would be removed from the denomi-
nator. The calculation of a surgery rate is generally done
only once. However, we did not have this information and
were, therefore, unable to make this adjustment. Still, the
overall rate of these surgeries is so low that this adjustment
would have a minimal effect on our results and would
tend to result in underestimates of practice variation.
Data analysis. The calculations for surgery rates in each
state were generated by dividing the total number of pro-
cedures for men and women by the age/sex-adjusted RA
population. For example, California, in which 170 arthro-
plasties were performed, has an RA population of 126,249,
which equates to a procedure rate of 13.5 arthroplasties
per 10,000 RA patients for 1996 and 1997, or an annual
rate of 6.7 per 10,000 RA patients. Logistic regression
provided a comparison of the probability of having a pro-
cedure across the 19 sampled states, analyzing the extent
of state-to-state variation. In this regression, the state was
the predictor variable and receipt of the procedure was the
outcome variable. For this analysis, California was chosen
as the reference group to which all other states were com-
pared, because it was the most populous state, and because
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we had no reason to suspect any particular state to display
significant variations in practice patterns compared with
other states.
To evaluate significant differences in procedure rates
between men and women, we performed chi-square ana-
lysis and generated odds ratios (ORs) and 95% confidence
intervals (95% CI). Student’s t-test was performed to com-
pare the difference in mean age between men and women
for each procedure. Other analyses included Pearson’s cor-
relation coefficient to measure the relationship between
each procedure’s incidence rate and the density of hand
surgeons across states. For the correlation between arthro-
desis and the other variables (tenosynovectomy, arthro-
plasty, and surgeon), Oregon was an outlier because it had
a rate of arthrodesis that was out of proportion to the other
states. Thus, this state was omitted from the analysis. All
analyses were performed with STATA version 6.0 (Stata
Corporation, College Station, TX) and SAS version 6.12
(SAS Institute, Cary, NC) statistical software packages, and
statistical significance was set at two-sided P  0.05.
RESULTS
Of the procedures we evaluated, Medicare covered 44–
64% of the patients, private health insurance covered 29–
38%, and fewer than 7% of the patients were uninsured.
Of the 772 hospitals included in the sample population,
427 (55%) performed at least 1 arthroplasty, 214 (28%)
performed at least 1 arthrodesis, and 601 (78%) performed
at least 1 tenosynovectomy. The distribution of the proce-
dures was almost evenly split between reconstructive and
prophylactic procedures: 52% versus 48%, respectively.
Of the reconstructive procedures, 34% were arthroplasty
and 18% were arthrodesis techniques. The length of hos-
pital stay was 1 day for 50% of fusions, 50% of arthroplas-
ties, and 69% of tenosynovectomies; the remainder of the
cases generally stayed 5 or fewer days. The percentage of
procedures performed in the urban teaching and nonteach-
ing hospitals was evenly split, with urban hospitals ac-
counting for approximately 90% of the procedures per-
formed. Patient demographics were similar across the 3
procedures, except for age and sex.
Table 1 illustrates procedure rates for men compared
with women. Women outnumbered men in arthroplasty
(7.7 versus 2.3, respectively; OR  3.36, P  0.001) and in
arthrodesis procedures (3.4 versus 2.6, respectively; OR 
1.3, P  0.009). However, women were less likely to re-
ceive tenosynovectomy procedures (5.8 versus 13.9, re-
spectively; OR  0.42, P  0.001). In addition, tenosyno-
vectomy procedures were associated with a significantly
younger age at treatment for men compared with women
(54 versus 59 years, respectively; P  0.001).
Table 2 displays the annual rates for each procedure
along with the 95% CIs for each of the sampled states.
Large variations in procedure rates across the 19 states
were found. These variations were highly significant for all
3 procedures (P  0.0001), with the difference in rates
between the highest and lowest states varying by a factor of
9.4 in arthroplasty, 11.7 in arthrodesis, and 9.5 in tenosy-
novectomy procedures.
The Pearson correlation matrix of procedure rates and
density of surgeons by state is seen in Table 3. The eval-
uation of one procedure rate with another revealed a
strong positive correlation between the 2 reconstructive
procedures, arthroplasty and arthrodesis (r  0.80). This
relationship is visually displayed in Figure 1. However,
tenosynovectomy rates were only modestly correlated
with arthroplasty and arthrodesis rates (r  0.20 and 0.23,
respectively). Therefore, states that perform more recon-
structive procedures are only slightly more likely to per-
form prophylactic procedures. Each state’s density of hand
Table 1. Differences in procedure rates between women and men
Procedure rate (95% CI)*
Odds ratio† PMen Women
Arthroplasty 2.3 (1.7–3.0) 7.7 (7.0–8.5) 3.36 0.001
Arthrodesis 2.6 (2.0–3.3) 3.4 (2.9–3.9) 1.30 0.009
Tenosynovectomy 13.9 (12.4–15.4) 5.8 (5.2–6.5) 0.42 0.001
* Procedures rates and 95% confidence intervals (95% CI) calculated per 10,000 RA population.
† Odds ratio compares the procedure rate in women with the procedure rate in men.
Table 2. Annual rates of arthroplasty, arthrodesis, and
tenosynovectomy procedures in the sampled states*
State Arthroplasty Arthrodesis Tenosynovectomy
AZ 4.1 (2.5–6.5) 2.0 (0.9–3.7) 14.8 (11.5–18.7)
CA 6.7 (5.8–7.8) 3.2 (2.6–4.0) 10.9 (9.6–12.2)
CO 2.9 (1.5–5.1) 1.7 (0.7–3.5) 5.8 (3.8–8.7)
CT† — — 12.2 (9.1–16.1)
FL 6.7 (5.5–8.0) 2.2 (1.5–3.0) 7.7 (6.4–9.1)
IL 3.2 (2.3–4.3) 2.0 (1.3–3.0) 6.4 (5.1–8.0)
IA 10.3 (7.4–13.9) 3.0 (1.6–5.3) 2.0 (0.9–4.0)
KS 6.4 (4.0–9.8) 2.2 (0.9–4.4) 2.8 (1.3–5.2)
MA 7.1 (5.4–9.2) 2.7 (1.7–4.1) 4.4 (3.2–6.0)
MD 7.8 (5.5–10.6) 4.3 (2.7–6.5) 10.8 (8.1–14.1)
MO 4.9 (3.4–6.9) 2.0 (1.1–3.3) 6.7 (4.9–9.0)
NJ 4.5 (3.2–6.1) 0.9 (0.4–1.8) 9.9 (7.9–12.2)
NY 4.8 (3.8–5.8) 2.4 (1.7–3.2) 4.1 (3.3–5.1)
OR 5.9 (3.8–8.7) 10.5 (7.6–14.1) 16.1 (12.5–20.5)
PA 13.2 (11.5–15.1) 8.0 (6.7–9.5) 12.6 (11.0–14.4)
SC 1.4 (0.5–3.2) 1.4 (0.5–3.2) 1.7 (0.6–3.6)
TN 2.6 (1.5–4.2) 2.6 (1.5–4.2) 6.9 (5.0–9.3)
WA 2.2 (1.2–3.6) 3.3 (2.0–5.0) 3.0 (1.8–4.6)
WI 11.5 (9.1–14.4) 4.2 (2.8–6.1) 11.1 (8.7–13.9)
* Annual procedure rates (95% confidence interval) were calcu-
lated per 10,000 rheumatoid arthritis patients.
† Connecticut did not report any arthroplasty or arthrodesis proce-
dures.
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surgeons was then compared with the different procedure
rates. There was no evidence that greater surgeon density
was associated with greater arthroplasty, arthrodesis, or
tenosynovectomy rates, and the trend actually went in the
opposite direction (r  –0.37, –0.18, and –0.12, respec-
tively).
DISCUSSION
Rheumatoid arthritis is a crippling systemic disease that
affects an estimated 1% of the US population at the prime
of their lives (1). Treatment options are limited, with no
cure available. Medical management is aimed at limiting
synovial proliferation and slowing the progression of
joint destruction. Surgical options for hand deformities
are also limited, defined as either reconstructive (arth-
rodesis or arthroplasty) or prophylactic (tenosynovecto-
my). Unfortunately, there is little information available
on these procedures from rigorous outcomes research or
randomized clinical trials, forcing physicians to rely on
uncontrolled case series for clinical decision making.
Although RA differentially affects women, one must still
consider the possibility of differences in health care deliv-
ery based on patient sex. Many studies have aroused con-
cern regarding underutilization of surgical interventions
in women, such as coronary revascularization, renal trans-
plantation, and hip or knee arthroscopy (5–8). In our ana-
lysis, women were 3.4 times more likely than men to
receive arthroplasty procedures and 1.3 times more likely
to receive arthrodesis procedures compared with men.
However, men were 2.4 times more likely than women to
receive tenosynovectomy procedures. Conclusions from
these results are limited due to a lack of information
regarding the patients’ disease severity and willingness
to undergo surgery. Because men have higher rates of
the prophylactic procedure—tenosynovectomy—and re-
ceive this procedure at a younger age than women, the
question must be raised whether men are receiving more
aggressive care than women. In addition, variations in
procedure rates between the sexes may be the result of
differences in disease manifestations, patient prefer-
ences, or physician biases and deserves further investi-
gation.
The literature regarding treatment of the rheumatoid
hand is controversial, with the efficacy of prophylactic
tenosynovectomy often at the crux of the debate (9,12–14).
Surgeons complain of exclusion from RA management
teams, as they are often called on as a source of last resort
when all else fails (15). In contrast, rheumatologists por-
tray synovectomy procedures as delaying strategies with
minimal long-term efficacy (16). Many rheumatologists de-
fine the role of surgery as a salvage technique and are
reluctant to consider surgery in the early stages of the
disease (17). Our results indicate that some physicians
believe in the efficacy of prophylactic procedures in the
RA hand, as tenosynovectomy accounted for 48% of the
procedures studied. This is surprising considering the lack
of confidence in the rheumatology literature regarding pro-
phylactic procedures on RA hands (16). Furthermore, ad-
vances in technology have improved arthroplasty out-
comes (18,19), which may alleviate some of the pressure
on surgeons to intervene early with prophylactic proce-
dures on functional hands. However, we do not know if
surgeons are performing prophylactic procedures at higher
or lower rates than in the past, given the changes in med-
ical management, arthroplasty materials, and referral pat-
terns.
Variations in practice patterns can arise when multiple
clinical options are available, particularly when there is
uncertainty about optimal management. For example,
greater geographic variation exists with hysterectomy than
with colectomy rates, due to greater treatment options for
uterine fibroids and dysfunctional bleeding (4). Treat-
ments considered to be the universal standard usually
have limited practice pattern variations. Studying practice
patterns is important for delineating clinical conditions for
which intervention decisions may need more rigorous
evaluation. Although many factors can contribute to vari-
ations, such as differences in illness rates, environmental
conditions, patient preferences, access to care, and eco-
nomic incentives, a large percentage of practice variations
can be explained by disagreement among physicians re-
garding appropriate therapy (4). Generally, physicians lack
consensus in patient management when treatment out-
comes are poorly defined (4). The significant variation in
procedure rates across states in our analyses was not sur-
Table 3. Associations between procedure rates and surgeon density by state*
Arthrodesis Tenosynovectomy Surgeon density
Arthroplasty 0.80 0.20 0.37
Arthrodesis — 0.23 0.18
Tenosynovectomy — 0.12
* Data are Pearson’s correlation coefficients. Surgeon density was calculated from the total number of
hand surgeons in each state divided by that state’s population.
Figure 1. Correlation between rates of arthroplasty and arthrode-
sis by state. * Arthroplasty and arthrodesis rates are per 10,000
rheumatoid arthritis patients.
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prising, given the lack of consensus in the literature re-
garding the treatment of the rheumatoid hand. We ex-
pected to find less variation in the rates of end-stage
procedures because the literature appears less controver-
sial in these areas. However, we found a higher than ex-
pected positive correlation between arthroplasty and arth-
rodesis procedures within each state. Thus, a state likely to
perform one type of end-stage procedure was also likely to
perform the other type. The reason for this correlation—
patient preference, disease manifestations, or physician
preference—cannot be elucidated from our data. However,
these procedures are often used in combination to maxi-
mize stability and function, which may account for some
of the correlation. For example, proximal interphalangeal
fusions are combined with metacarpophalangeal arthro-
plasties to correct for swan neck deformities. Nevertheless,
our study clearly demonstrates that one of the most influ-
ential factors in the treatment of the rheumatoid hand is
the state in which the patient lives. Therefore, we now
need to determine the reasons behind such wide variation
in treatment.
From a health policy perspective, concern exists regard-
ing the cost of specialized care, including hand surgery. In
general, the US has an overabundance of specialized phy-
sicians, contributing to the escalating costs of health care
(20). Physicians are believed to sometimes induce the de-
mand for their own services; therefore, one attempt to
control healthcare costs is to control the number of spe-
cialty providers (21). In Canada, health policy experts
attribute practice pattern variations to physician density,
believing that physicians induce demand for their ser-
vices, which increases health care costs. Plans for restruc-
turing the fee schedules of specialty physicians and relo-
cating specialists to rural locations have been discussed to
unify practice patterns. However, an orthopedic study of
knee replacement rates showed surgery rates and density
of surgeons to be unrelated, arguing against the restructur-
ing efforts (22). Similar to the Canadian study, we found
no evidence that specialized surgeons are inducing de-
mand for their services. We found no significant relation-
ship between the density of hand surgeons in a state and
the rate of hand procedures in RA patients. Answering the
question of specialty physician-induced demand is chal-
lenging and may be better approached at the county rather
than the state level. However, the database does not pro-
vide zip codes, so the possibility of physician-induced
demand at the county or hospital level cannot be evalu-
ated. In addition, because the HCUP database does not
identify the provider, we had no means of identifying
surgeons performing these procedures who were not
ASSH members. However, rheumatoid hand surgery is
very complex and, according to our data, 90% of the pro-
cedures were performed in urban areas with available
ASSH surgeons. Therefore, we believe that our sample of
ASSH members probably reflects the general membership
of physicians who care for these patients.
Although using a national database aids in the general-
izability of the study results, limitations still exist. For
example, the procedure rates for the sampled states were
probably underestimated, because we were unable to ac-
count for patients in the population already treated by
surgery and patients who had received outpatient surgery
(although the popularity of ambulatory surgery was at its
infancy at this time). Our study results were also limited to
the white patient population due to our limited sample
size of nonwhites. However, white people represent 92%
of RA patients in this country so we believe that our
sample adequately represented the study population (23).
Lastly, databases are susceptible to errors in coding, which
may underestimate or overestimate procedure rates. RA is
difficult to diagnose, and patients with inflammatory ar-
thritis may be incorrectly diagnosed as having RA. How-
ever, we used the most accurate method available to define
the RA population, which was through the use of ICD-
9-CM diagnostic codes.
In conclusion, the surgical treatment of the rheumatoid
hand is a complex multidimensional process with limited
evidence-based research and limited agreement among
physicians as to appropriate treatment modalities. Not sur-
prisingly, we found significant variations in physician
practice patterns on a national level, influenced both by
the state in which the procedure was performed and the
patient’s sex, but not by the density of hand surgeons. Our
future research initiatives will investigate whether this
variation represents differences in physician behavior or
differences in patients’ wants or needs.
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